Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lebrikizumab in adults with asthma inadequately controlled on ICS
NCT00930163Phase 2Completed
- Sponsor
- Genentech
- Start
- Jul 2009
- Primary completion
- Jul 2010
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of lebrikizumab in asthma, sponsored by Genentech. Started Jul 2009; status: completed.
02
Drugs
lebrikizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00930163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00930163.